NEW ORLEANS -- Among patients with heart failure, conduction system pacing-guided cardiac resynchronization therapy was associated with improvements in left ventricular ejection fraction (LVEF) ...
Abbott's investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system is specifically designed to deliver pacing to the left bundle branch area, activating the heart's natural ...
In the largest multicenter study to date on left bundle-branch area pacing (LBBAP), the technique was shown to be feasible as a primary pacing technique for treating bradyarrhythmias and heart failure ...
Although His-bundle pacing (HBP) has been gaining ground as an alternative to standard biventricular (BiV) pacing for cardiac resynchronization therapy (CRT) in heart failure, and may offer some ...
SAN FRANCISCO -- His corrective pacing wasn't better than conventional biventricular cardiac resynchronization therapy (BiV CRT) in the first head-to-head pilot trial, although crossover appeared to ...
MARLBOROUGH, Mass., Sept. 17, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the indication for ...
Abbott announced the successful completion of the world's first in-human leadless left bundle branch area pacing (LBBAP) procedures using the company's investigational AVEIR Conduction System Pacing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback